AI assistant
Novonesis AS Director's Dealing 2021
3377_rns_2021-02-17_06fa4526-d680-4e8c-9601-ef3e7410f27d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
Details of the person discharging managerial responsibilities/person closely associated
| Name | Claus Crone Fuglsang |
|---|---|
Reason for notification
| Position/status | Executive Vice President, Head of Research & Development |
|---|---|
| Initial notification/amendment | Initial notification |
Details of the issuer
| Entity | Novozymes A/S |
|---|---|
| LEI code | 529900T6WNZXD2R3JW38 |
Details of the transaction(s)
| Description:
Financial instrument
Identification code | Shares
ISIN DK0060336014 |
| --- | --- |
| Nature of the transaction | Exercise of share options (purchase) from incentive program |
| --- | --- |
| Place(s) of transaction(s),
price(s) and volume(s) | Place(s) | Price(s) | Volume(s) |
| --- | --- | --- | --- |
| | Novozymes' custody account | 249.40 | 7,195 shares |
| Aggregated information | Number of shares: 7,195
Average price, DKK: 249.40
Transaction value, DKK: 1,794,433 |
| --- | --- |
| Date of the transaction | 2021-02-16 (13:18:00 CET) |
| --- | --- |
February 17, 2021
Company announcement No. 08
Contact information
Tobias Cornelius Björklund
+45 3077 8682
Carl Ahlgren
+1 919 702 6144
Ulrik Wu Svare
+45 3077 3187
Novozymes A/S
Krog shoejvej 36
2880 Bagsvaerd
Denmark
Phone: +45 4446 0000
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38
Trading by management and close relations of management. Company announcement No. 08
2/3
Details of the person discharging managerial responsibilities/person closely associated
| Name | Claus Crone Fuglsang |
|---|---|
Reason for notification
| Position/status | Executive Vice President, Head of Research & Development |
|---|---|
| Initial notification/amendment | Initial notification |
Details of the issuer
| Entity | Novozymes A/S |
|---|---|
| LEI code | 529900T6WNZXD2R3JW38 |
Details of the transaction(s)
| Description: | |
|---|---|
| Financial instrument | Shares |
| Identification code | ISIN DK0060336014 |
| Nature of the transaction | Sale of shares |
| Place(s) of transaction(s), price(s) and volume(s) | Place(s) |
| --- | --- |
| See appendix | |
| Aggregated information | Number of shares: 7,195 |
| Average price, DKK: 405.695552 | |
| Transaction value, DKK: 2,918,979.50 | |
| --- | --- |
| Date of the transaction | 2021-02-16 |
Rethink Tomorrow
novozymes
Trading by management and close relations of management. Company announcement No. 08
3/3
Appendix
| Date & Time CET | Exchange | No. of Shares | Price |
|---|---|---|---|
| 16.feb.2021 13:49:10 | XOFF | 65 | 405.9 |
| 16.feb.2021 13:50:05 | XOFF | 63 | 405.9 |
| 16.feb.2021 13:20:03 | XOFF | 267 | 406 |
| 16.feb.2021 13:21:39 | XOFF | 76 | 406 |
| 16.feb.2021 13:21:41 | XOFF | 186 | 406.2 |
| 16.feb.2021 13:21:42 | XOFF | 189 | 406.2 |
| 16.feb.2021 13:24:06 | XOFF | 237 | 406.25 |
| 16.feb.2021 13:24:42 | XOFF | 12 | 406.2 |
| 16.feb.2021 13:24:42 | XOFF | 57 | 406.2 |
| 16.feb.2021 13:24:42 | XOFF | 100 | 406.3 |
| 16.feb.2021 13:24:42 | XOFF | 85 | 406.2 |
| 16.feb.2021 13:25:21 | XOFF | 81 | 406.1 |
| 16.feb.2021 13:25:21 | XOFF | 107 | 406.1 |
| 16.feb.2021 13:26:46 | XOFF | 36 | 405.9 |
| 16.feb.2021 13:26:46 | XOFF | 100 | 405.9 |
| 16.feb.2021 13:26:46 | XOFF | 140 | 405.9 |
| 16.feb.2021 13:26:46 | XOFF | 47 | 405.8 |
| 16.feb.2021 13:26:47 | XOFF | 190 | 405.8 |
| 16.feb.2021 13:26:49 | XOFF | 189 | 405.8 |
| 16.feb.2021 13:28:16 | XOFF | 60 | 405.7 |
| 16.feb.2021 13:28:16 | XOFF | 188 | 405.6 |
| 16.feb.2021 13:28:23 | XOFF | 188 | 405.7 |
| 16.feb.2021 13:28:23 | XOFF | 187 | 405.8 |
| 16.feb.2021 13:28:23 | XOFF | 68 | 405.9 |
| 16.feb.2021 13:28:59 | XOFF | 187 | 405.6 |
| 16.feb.2021 13:29:03 | XOFF | 186 | 405.6 |
| 16.feb.2021 13:29:38 | XOFF | 189 | 405.6 |
| 16.feb.2021 13:32:23 | XOFF | 187 | 405.5 |
| 16.feb.2021 13:32:23 | XOFF | 188 | 405.5 |
| 16.feb.2021 13:32:56 | XOFF | 63 | 405.6 |
| 16.feb.2021 13:32:56 | XOFF | 188 | 405.5 |
| 16.feb.2021 13:32:56 | XOFF | 186 | 405.5 |
| 16.feb.2021 13:33:00 | XOFF | 329 | 405.5 |
| 16.feb.2021 13:33:00 | XOFF | 329 | 405.5 |
| 16.feb.2021 13:33:00 | XOFF | 329 | 405.5 |
| 16.feb.2021 13:33:00 | XOFF | 314 | 405.5 |
| 16.feb.2021 13:33:00 | XOFF | 80 | 405.5 |
| 16.feb.2021 13:33:00 | XOFF | 329 | 405.5 |
| 16.feb.2021 13:33:00 | XOFF | 178 | 405.5 |
| 16.feb.2021 13:33:00 | XOFF | 524 | 405.5 |
| 16.feb.2021 13:33:00 | XOFF | 410 | 405.5 |
| 16.feb.2021 13:34:55 | XOFF | 64 | 405.4 |
| 16.feb.2021 13:34:55 | XOFF | 17 | 405.35 |
Rethink Tomorrow
novozymes